MyopiaNCT00346593
Investigation of the Clinical Performance of Silicone Hydrogel Contact Lenses During Continuous Wear
A study testing Silicone hydrogel contact lens in people with Myopia, run by University of Melbourne at 1 site in Australia.
Trial summary
The primary purpose of this study is to investigate the clinical performance of a new silicone hydrogel contact lens during continuous wear (up to 30 nights) over a period of 24 months. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- Myopia
- What is being tested?
- Silicone hydrogel contact lens
- Type of treatment
- Medical device
- How many people
- Not given
- Where
- 1 siteAustralia
- Study dates
- May 2004to Dec 2006
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Adult
Who may be able to join
- Has had an oculo-visual examination in the last 2 years.
- Is correctable to at least 6/7.5 distance visual acuity in each eye with spherical contact lenses.
- Is a current soft contact lens wearer.
- Has no clinically significant anterior eye findings.
- Has no other active ocular disease.
Who cannot join
- Has any systemic disease that might interfere with contact lens wear
- Is using any systemic or topical medications that will affect ocular health.
- Has any pre-existing ocular irritation that would preclude contact lens fitting.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that would affect the wearing of contact lenses.
- Has undergone corneal refractive surgery.
- Is pregnant, lactating or planning a pregnancy.
Trial locations and contacts
1 site in 1 country.
About this study
The primary purpose of this study is to investigate the clinical performance of a new silicone hydrogel contact lens during continuous wear (up to 30 nights) over a period of 24 months.
- Conditions
- Myopia
- Being tested
- Silicone hydrogel contact lens
- Medical subject headings
- Myopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Silicone hydrogel contact lensDevice
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jun 2006 (estimated)
- Study startMay 2004
- Study completionDec 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MyopiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind
Sponsor and investigators
- Lead sponsor
- University of Melbourne
- Sponsor type
- University, hospital or other
- Collaborators
- Clinical Vision Research Australia, Cooper Companies
- Investigators
- Carol Lakkis, BScOptom PhD, Principal investigator, Clinical Vision Research Australia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00346593
- Sponsor's protocol ID
- H03 010
- Status last verified
- Feb 2007
- First submitted
- 29 Jun 2006
- Last updated
- 12 Feb 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Clinical Performance of Silicone Hydrogel Contact Lenses During Continuous Wear
- ClinicalTrials.gov ID
- NCT00346593
- Acronym / sponsor ID
- H03 010
- Conditions
- Myopia
- Study type
- Interventional
- Recruitment status
- Completed
- Lead sponsor
- University of MelbourneUniversity, hospital or other
- Collaborators
- Clinical Vision Research Australia, Cooper Companies
- Study start
- May 2004
- Study completion
- Dec 2006
- First posted
- 30 Jun 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary purpose of this study is to investigate the clinical performance of a new silicone hydrogel contact lens during continuous wear (up to 30 nights) over a period of 24 months.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Has had an oculo-visual examination in the last 2 years.
- Is correctable to at least 6/7.5 distance visual acuity in each eye with spherical contact lenses.
- Is a current soft contact lens wearer.
- Has no clinically significant anterior eye findings.
- Has no other active ocular disease.
Key exclusion criteria (6 listed)
- Has any systemic disease that might interfere with contact lens wear
- Is using any systemic or topical medications that will affect ocular health.
- Has any pre-existing ocular irritation that would preclude contact lens fitting.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that would affect the wearing of contact lenses.
- Has undergone corneal refractive surgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Silicone hydrogel contact lens | Device | – |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2007.
Related trials for Myopia
Recruiting
Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
Pre-myopia, Myopia
Not yet recruiting
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment
Myopia, Myopia Progressing
Active, not recruiting
Effect of IOP Lowering on Progressive HM
High Myopia, Intraocular Pressure
Recruiting
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Hyperopia and Myopia
Recruiting
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
Myopia, Myopia Progression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carol Lakkis, BScOptom PhD principal investigator
Clinical Vision Research Australia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Silicone hydrogel contact lens in people with Myopia, run by University of Melbourne at 1 site in Australia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Feb 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2007; AzTrials last refreshed its copy on 8 Nov 2026.